TrialThe Journal of clinical investigation2013

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Mahadeo A Sukhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.